Table 2 Univariate comparison of patients not hospitalized vs. hospitalized among symptomatic SARS-CoV-2 positive children and adolescents diagnosed between 3/12/2020 and 9/28/2020

Age, mean ± SD, median (IQR)

12.1 ± 6.0, 14.1 (7.4–17.3)

10.0 ± 7.7, 12.2 (0.9–17.1)

0.95 (0.90-1.00)

0.077^b

Male gender

459 (47.9 %)

18 (43.9 %)

0.9 (0.5–1.6)

0.619^a

Race

0.086^a

 White

760 (79.2 %)

29 (70.7 %)

Reference

 Black

118 (12.3 %)

10 (24.4 %)

2.2 (1.1–4.7)

 Asian

41 (4.3 %)

2 (4.9 %)

1.3 (0.3–5.5)

 Other

40 (4.2 %)

0 (0.0 %)

0.0 (0.0-∞)

 Hispanic

188 (19.6 %)

15 (36.6 %)

2.4 (1.2–4.6)

0.008^a

 Black or Hispanic

304 (31.7 %)

25 (61.0 %)

3.4 (1.8–6.4)

< 0.001^a

Body mass index, mean ± SD, median, BMI Category

21.9 ± 5.5, 21.0 (18.0-24.4)

22.5 ± 7.7, 20.9 (16.1–25.6)

1.02 (0.96–1.08)

0.849^b

0.435^a

 Underweight

153 (28.4 %)

12 (35.3 %)

1.49 (0.67–3.3)

 Normal weight 

266 (49.4 %)

14 (41.2 %)

Reference

 Overweight

72 (13.4 %)

3 (8.8 %)

0.79 (0.22–2.83)

 Obese

47 (8.7 %)

5 (14.7 %)

2.02 (0.70–5.88)

Clinical Symptoms

0.229^a

 Anosmia (loss of smell)

162 (16.9 %)

4 (9.8 %)

0.5 (0.2–1.5)

 Shortness of breath(dyspnea)

81 (8.4 %)

17 (41.5 %)

7.7 (4.0-14.9)

< 0.001^a

 Sore throat

357 (37.2 %)

4 (9.8 %)

0.2 (0.1–0.5)

< 0.001^a

 Vomiting

12 (1.3 %)

4 (9.8 %)

8.5 (2.6–27.7)

< 0.001^a

 Fever > 100.4 F

314 (32.7 %)

23 (56.1 %)

2.6 (1.4–4.9)

0.002^a

 Headache

420 (43.8 %)

4 (9.8 %)

0.2 (0.05–0.39)

< 0.001^a

 Hypoxia

1 (0.1 %)

11 (26.8 %)

351.3 (43.9-2809.2)

< 0.001^a

 Abdominal pain

74 (7.7 %)

8 (19.5 %)

2.9 (1.3–6.5)

0.007^a

 Nausea or vomiting

139 (14.5 %)

8 (19.5 %)

1.4 (0.6–3.2)

0.374 ^a

Pre-existing condition(s)

150 (15.6 %)

27 (65.9 %)

10.4 (5.3–20.3)

< 0.001^a

 Immunocompromising condition

4 (0.4 %)

5 (12.2 %)

33.2 (8.5-128.7)

< 0.001^a

 Neurologic condition

24 (2.5 %)

9 (22.0 %)

11.0 (4.7–25.5)

< 0.001^a

 Cardiovascular disease

19 (2.0 %)

8 (19.5 %)

12.0 (4.9–29.4)

< 0.001^a

 Chronic renal disease

5 (0.5 %)

3 (7.3 %)

15.1 (3.5–65.4)

< 0.001^a

 Chronic lung disease

69 (7.2 %)

8 (19.5 %)

3.1 (1.4-7.0)

< 0.004^a

 Diabetes

9 (0.9 %)

1 (2.4 %)

2.6 (0.3–21.3)

< 0.344^a

 Other chronic condition

53 (5.5 %)

11 (26.8 %)

6.3 (3.0-13.2)

< 0.001^a